RecruitingNot Applicable

Danish Angle Closure Prevention Trial

Denmark242 participantsStarted 2023-09-01

Plain-language summary

To determine whether primary angle closure suspects (PACS) in a Caucasian population benefit from prophylactic laser iridotomy.

Who can participate

Age range40 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Primary angle closure suspect: ≥180 degrees (cumulative) irido-trabecular contact on darkroom gonioscopy, IOP\<21mmHg, no peripheral anterior synechiae, no glaucomatous optic neuropathy * Best-corrected visual acuity (BCVA) \>0.8 on both eyes * Caucasian Exclusion Criteria: * Pseudophakia * Previous iridotomy * Clinically significant cataract with indication for surgery, * Gaucoma * Uveitis * Unstable retinal conditions * Ocular malignancies * PEX * PDS * Systemic or ocular corticosteroid treatment

What they're measuring

Intraocular pressure

Timeframe: 5 year

Glaucoma

Timeframe: 5 year

Acute Primary Angle Closure

Timeframe: 5 year

Trial details

NCT IDNCT06077253

SponsorUniversity of Aarhus

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2029-09-01

Contact for this trial

Niklas Telinius, PhD, DMSc

+4530238533 telinius@me.com

View on ClinicalTrials.gov More Primary Angle Glaucoma Closure Suspect trials